Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solifenacin for prevention of bladder spasms after urethroplasty
ChiCTR-IPR-17011523Phase 4Recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Jun 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of solifenacin in cystospasm (2 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoints: Severity of bladder spasm, Spasm frequency and 1 more. Started Jun 2017; status: recruiting.
02
Drugs
solifenacin
03
Conditions
cystospasm
Beyond the preview
Go deeper on ChiCTR-IPR-17011523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17011523.